| Company Name | Concord Biotech Limited |
| Open Date | 04-08-2023 |
| Close Date | 08-08-2023 |
| Exchange | NSE BSE |
| Lot Size | 20 Shares |
| Issue Price | ₹705 to ₹741 per share |
| Issue Size | 2,09,25,652 shares |
| Application Amount | Min. Inv. - ₹ 14,820 (20 shares) Max. Inv. - ₹ 1,92,660 (260 shares) |
| Recommendation | Apply |
Company was incorporated in the year 1984 and has its registered office in Gujarat. Company is an India-based biopharma company. The company manufactures (i) bio-pharmaceutical APIs through fermentation and semi-synthetic processes, across the therapeutic areas of immunosuppressants, oncology and anti-infectives; and (ii) formulations,
The company supplies to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India. As on March 31, 2023, Company has 1,234 employees as on payroll.
| For the Period Ended | Mar-21 | Mar-22 | Mar-23 |
| Total Assets | 1,18,254.60 | 1,31,279.50 | 1,51,398.40 |
| Net Assets | 99,937.30 | 1,10,322.30 | 1,29,000 |
| Total Borrowings | 8,634.90 | 6,058.60 | 3,123.60 |
| Total Revenue | 63,075.00 | 73,634.90 | 88,847.70 |
| Profit After Tax | 23,488.70 | 17,492.90 | 24,008.40 |
| Opening Date | 04/08/2023 |
| Closing Date | 08-08-2023 |
| Basis of Allotment | 11-08-2023 |
| Initiation of Refunds | 14-08-2023 |
| Credit of Shares to Demat | 17-08-2023 |
| Listing Date | 18-08-2023 |
| Achieve the benefits of listing the equity shares |
| Carry out Offer for Sale |
| Registered Office | Concord Biotech Limited 1482-86, Trasad Road Dholka, Ahmedabad – 382225 |
| Phone | 079-6813 8700 |
| complianceofficer@concordbiotech.com | |
| Website | http://www.concordbiotech.com/ |
| Concord Biotech DRHP |
| Concord Biotech RHP |
| Name | Link Intime India Private Limited |
| Phone | +91-22-4918 6270 |
| concordbiotech.ipo@linkintime.co.in | |
| Website | https://linkintime.co.in/mipo/ipoallotment.html |
| QIB Shares Offered | Not more than 50% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| Pre Issue Share Holding (Promoters) | 44.08% |
| Post Issue Share Holding (Promoters) | 24.65% |